GSK Says New Claim Has No Evidence In Avandia MDL
GlaxoSmithKline PLC told a Pennsylvania federal court Thursday that third-party payors in multidistrict litigation alleging the company misrepresented the safety of its Avandia diabetes drugs are now claiming for the first...To view the full article, register now.
Already a subscriber? Click here to view full article